Extragenital Sexually Transmitted Infections Testing During COVID-19 Pandemic Among Youth Involved in the Juvenile Justice System

J Correct Health Care. 2023 Oct;29(5):324-328. doi: 10.1089/jchc.22.08.0059. Epub 2023 Aug 30.

Abstract

Studies have shown lower screening for sexually transmitted infections (STIs) during the COVID-19 pandemic. It is unclear how the pandemic affected STI testing among juvenile justice-involved youth, especially for extragenital gonorrhea and chlamydia. Retrospective chart review was conducted between March 2020 and June 2021 utilizing electronic health records of youth seen at a preadjudication facility in the southwest United States. Rates of extragenital testing were compared with prepandemic rates. Overall, 574 youth were observed; 86% were male, mean age was 15.4 years, and 48.6% were Black. Of the youth reporting performing oral sex, 57% were tested for oropharyngeal STIs compared to 33.5% in 2018 to 2019. Twenty percent of those reporting anal receptive sex were tested for rectal infections compared to 25.9% before the pandemic. Pandemic testing for oropharyngeal STIs increased but rectal testing decreased. Overall, testing rates remained low.

Keywords: COVID-19 pandemic; adolescent; extragenital; juvenile justice; sexually transmitted infections.

MeSH terms

  • Adolescent
  • COVID-19*
  • Chlamydia Infections* / diagnosis
  • Chlamydia Infections* / epidemiology
  • Female
  • Gonorrhea* / diagnosis
  • Gonorrhea* / epidemiology
  • Gonorrhea* / prevention & control
  • HIV Infections* / epidemiology
  • Humans
  • Male
  • Pandemics
  • Retrospective Studies
  • Sexually Transmitted Diseases* / diagnosis
  • Sexually Transmitted Diseases* / epidemiology